Clinical Diagnostics News and Research

RSS

Overview of newly evolving technologies for diagnosing and monitoring HIV infections

Rising consumer awareness that early diagnosis and treatment can delay the progression of human immunodeficiency virus (HIV) to anti-immuno deficiency syndrome (AIDS) has had a telling impact on the sales of HIV tests.

2 Feb 2010

Intrinsic Bioprobes licenses diabetes biomarkers to Ortho-Clinical Diagnostics

Intrinsic Bioprobes today announced the exclusive licensing of two novel biomarkers for diabetes to Ortho-Clinical Diagnostics, Inc. (Raritan, NJ). The biomarkers are modified forms of blood-circulating proteins and have been linked with the presence of pre-diabetes and type 2 diabetes. The financial terms of the licensing agreement were not disclosed.

From Ortho-Clinical Diagnostics, Inc. 22 Jan 2010

Affomix, City of Hope collaborate in exploring next generation sequencing using digital proteomics

Affomix Corporation, a pioneer in high performance antibody technology, announced today a collaboration with City of Hope focused on establishing the clinical utility of “digital proteomics” with next generation sequencers. One of the nation’s top cancer research and treatment centers, City of Hope is a leading provider of molecular diagnostic testing services and an innovator in clinical genetics research.

19 Jan 2010

Sword Diagnostics launches Raman detection system for ultrasensitive immunoassays

Sword Diagnostics announced today the launch of its proprietary Raman detection system for ultrasensitive immunoassays. The system provides researchers with greater sensitivity which enables more accurate testing of low abundance markers.

18 Jan 2010

Bio-Rad Laboratories acquires Biotest AG's diagnostics businesses

Bio-Rad Laboratories, Inc., a multinational manufacturer and distributor of life science research and clinical diagnostics products, announced today that it has completed the purchase of certain diagnostics businesses of Biotest AG, including its diagnostics products in the areas of blood transfusion testing, transplantation, and infectious diseases for 45 million euros.

6 Jan 2010

BioPlex 2200 Anti-CCP test for early detection of RA launched

Bio-Rad Laboratories, Inc., a multinational manufacturer and distributor of life science research and clinical diagnostics products, and Axis-Shield plc, an international in-vitro diagnostics (IVD) company, today announced the launch of Bio-Rad's BioPlex® 2200 Anti-CCP test for the early detection of rheumatoid arthritis.

5 Jan 2010

Danaher offers GBP 50 million pounds for Genetix Group acquisition

Danaher Corporation announced today its intention to make a recommended cash takeover offer, through an indirect wholly owned subsidiary, to acquire all of the issued and to be issued shares of Genetix Group plc for 85 pence per share implying an aggregate price of approximately GBP 50 million pounds (USD $82 million) net of cash acquired.

From Danaher 18 Dec 2009

Advantages of Helicos BioSciences' single molecule sequencing technology presented

Helicos BioSciences Corporation announced today that, as previously disclosed, it has posted a presentation on its website regarding the advantages of Helicos’ single molecule sequencing technology in clinical diagnostics.

4 Dec 2009

Patent number for Microfluidic Valve Mechanism received

Microfluidic Systems, a privately-held company, announced today that they received patent number 7,607,641, entitled "Microfluidic Valve Mechanism". This patent covers a broad set of claims regarding the integration of a diaphragm membrane into a rigid body of a cartridge functioning as both a fluidic seal and cover of the cartridge, and as a valve mechanism for fluidics control within the cartridge.

16 Nov 2009

Health information technology's 11% combined annual growth rate to continue through 2013: Scientia Advisors

Health information technology (HIT) is the fastest growing segment of the $1 trillion global health care marketplace—and its “impressive” 11 per cent combined annual growth rate is likely to continue through 2013, according to a Scientia Advisors global industry review released today.

10 Nov 2009

Emerson Resources announces partnership with Bio Research

Emerson Resources, Inc., a premier pharmaceutical solutions company, today announced that it has formed a strategic partnership with Bio Research, a contract research organization that specializes in the agrichemical and related industries, to further extend its business development capabilities. The exclusive partnership leverages the expertise of industry veteran Robert Westbrook, CEO of Bio Research, who is spearheading Emerson Resources' intensified business development and sales efforts.

4 Nov 2009

Clinical data on the validation set 'Alzheimer patients versus healthy controls' for AclarusDx presented

ExonHit Therapeutics yesterday presented clinical data on the validation set “Alzheimer patients versus healthy controls” for AclarusDx™ (formerly EHT Dx21), its blood-based diagnostic test for the detection of Alzheimer’s disease (AD), at the 2nd Conference of Clinical Trials on Alzheimer’s Disease (CTAD) in Las Vegas, USA.

30 Oct 2009

Bio-Rad Laboratories to acquire diagnostic businesses of Biotest AG for 45 million euros

Bio-Rad Laboratories, Inc., a multinational manufacturer and distributor of life science research and clinical diagnostics products, announced today that it has signed an agreement to acquire certain diagnostic businesses of Biotest AG for 45 million euros.

24 Oct 2009

Focus Diagnostics' 2009 H1N1 influenza virus test granted FDA emergency use authorization

The U.S. Food and Drug Administration (FDA) today issued a second emergency use authorization (EUA) to Focus Diagnostics, the infectious disease diagnostics business of Quest Diagnostics Incorporated, for its 2009 H1N1 influenza virus test. With the EUA, Focus Diagnostics is the only company in the U.S. to offer test kits for detecting the pandemic 2009 H1N1 virus that the FDA has authorized for emergency use by CLIA high-complexity labs, which include certain hospital and regional labs.

19 Oct 2009

FDA approves Ortho Clinical Diagnostics' anti-HIV 1+2 test for use on VITROS 5600 & 3600 systems

Ortho Clinical Diagnostics today announced U.S. Food and Drug Administration (FDA) approval of a diagnostic assay for the detection of antibodies to human immunodeficiency virus (HIV) types 1+2 (Anti-HIV 1+2) for use on the VITROS® 5600 Integrated and VITROS® 3600 Immunodiagnostic Systems.

From Ortho-Clinical Diagnostics, Inc. 15 Oct 2009

Global POC market to increase from $12.8 billion in 2008 to $17.8 billion by 2014, says report

According to a new report distributed by Life Science Intelligence (LSI), the global point-of-care (POC) testing market will experience dramatic growth from $12.8 billion in 2008 to $17.8 billion by 2014.

14 Oct 2009

Johnson & Johnson announces financial results for the third quarter of 2009

Johnson & Johnson today announced sales of $15.1 billion for the third quarter of 2009, a decrease of 5.3% as compared to the third quarter of 2008. Operational results declined 2.8% and the negative impact of currency was 2.5%. Domestic sales declined 8.1%, while international sales declined 2.5%, reflecting operational growth of 2.4% and a negative currency impact of 4.9%.

13 Oct 2009

Premier Purchasing Partners awards new agreements for blood bank analyzers

Premier Purchasing Partners, LP, today announced new agreements for blood bank analyzers, reagents, consumables and service have been awarded to Biotest Diagnostics Corporation of Rockaway, N.J.; and Johnson & Johnson Health Care Systems Inc. of Piscataway, N.J., contracting on behalf of Ortho-Clinical Diagnostics, Inc. of Raritan, N.J.

13 Oct 2009

Diagnostics industry in Asia Pacific poised to present more growth opportunities

The global diagnostics industry has witnessed strong growth over the past few years. According to Frost & Sullivan, the diagnostics and monitoring sectors are poised to present more growth opportunities. According to Nitin Naik, Vice President of Frost & Sullivan's Asia Pacific Medical Technologies Division, the diagnostics and monitoring sectors in Asia Pacific are projected to provide more growth opportunities on the basis of the technology spending being channelled in these areas (80 percent).

13 Oct 2009

Bio-Rad cycle riders raise $73,055 during the Napa Valley Tour de Cure to benefit the ADA

Bio-Rad Laboratories, Inc. (NYSE: BIO) and (NYSE: BIO.B), a multinational manufacturer and distributor of life science research and clinical diagnostics products, helped raise approximately $1.1 million during the Napa Valley Tour de Cure, which took place on May 3 to benefit the American Diabetes Association.

1 Sep 2009

Clinical Diagnostics News and Research

Overview of newly evolving technologies for diagnosing and monitoring HIV infections

Intrinsic Bioprobes licenses diabetes biomarkers to Ortho-Clinical Diagnostics

Affomix, City of Hope collaborate in exploring next generation sequencing using digital proteomics

Sword Diagnostics launches Raman detection system for ultrasensitive immunoassays

Bio-Rad Laboratories acquires Biotest AG's diagnostics businesses

BioPlex 2200 Anti-CCP test for early detection of RA launched

Danaher offers GBP 50 million pounds for Genetix Group acquisition

Advantages of Helicos BioSciences' single molecule sequencing technology presented

Patent number for Microfluidic Valve Mechanism received

Health information technology's 11% combined annual growth rate to continue through 2013: Scientia Advisors

Emerson Resources announces partnership with Bio Research

Clinical data on the validation set 'Alzheimer patients versus healthy controls' for AclarusDx presented

Bio-Rad Laboratories to acquire diagnostic businesses of Biotest AG for 45 million euros

Focus Diagnostics' 2009 H1N1 influenza virus test granted FDA emergency use authorization

FDA approves Ortho Clinical Diagnostics' anti-HIV 1+2 test for use on VITROS 5600 & 3600 systems

Global POC market to increase from $12.8 billion in 2008 to $17.8 billion by 2014, says report

Johnson & Johnson announces financial results for the third quarter of 2009

Premier Purchasing Partners awards new agreements for blood bank analyzers

Diagnostics industry in Asia Pacific poised to present more growth opportunities

Bio-Rad cycle riders raise $73,055 during the Napa Valley Tour de Cure to benefit the ADA

Event guide: 4th LNP Formulation & Process Development Summit eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News